Heavy Pharmaceutical Holdings announced in the evening that the cumulative deviation value of the closing price increase of the company's stock exceeded 20% for two consecutive trading days on December 10 and December 11, 2025, which is an abnormal fluctuation in stock trading. After verification, there are no corrections or additions to the information disclosed by the company in the early stages. Recently, the company's business situation is normal, and there have been no major changes in the internal and external business environment. The controlling shareholders and actual controllers of the company have no important matters relating to the company that should be disclosed but not disclosed or are in the process of planning. During the period of abnormal fluctuations in stock trading, the controlling shareholders and actual controllers of the company did not trade the company's shares.

Heavy Pharmaceutical Holdings announced in the evening that the cumulative deviation value of the closing price increase of the company's stock exceeded 20% for two consecutive trading days on December 10 and December 11, 2025, which is an abnormal fluctuation in stock trading. After verification, there are no corrections or additions to the information disclosed by the company in the early stages. Recently, the company's business situation is normal, and there have been no major changes in the internal and external business environment. The controlling shareholders and actual controllers of the company have no important matters relating to the company that should be disclosed but not disclosed or are in the process of planning. During the period of abnormal fluctuations in stock trading, the controlling shareholders and actual controllers of the company did not trade the company's shares.